ENLVVSGTBP• 3 Months (Normalized)
ENLV vs GTBP (Enlivex Ltd. vs GT Biopharma Inc.)
Showing Closing Date Range from Jun 27 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ENLV Performance $0.57
-93.42%
Enlivex Ltd.
Normalized Baseline0.00%
GTBP Performance $7.1
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-93.42 pts
GTBP outperforming by 93.42 percentage points
ENLVGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ENLV GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | ENLV Price | ENLV Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $0.57 | -93.42% | $- | - | |
| Sep 23, 2026 | $0.64 | -92.64% | $7.10 | +1513.64% | -1606.28% |
| Sep 21, 2026 | $0.69 | -92.03% | $7.18 | +1531.82% | -1623.85% |
| Sep 18, 2026 | $0.81 | -90.72% | $7.16 | +1527.27% | -1617.99% |
| Sep 17, 2026 | $0.73 | -91.64% | $7.49 | +1602.27% | -1693.91% |
| Sep 16, 2026 | $0.81 | -90.68% | $7.81 | +1675.00% | -1765.68% |
| Sep 15, 2026 | $0.88 | -89.85% | $9.00 | +1945.45% | -2035.30% |
| Sep 14, 2026 | $0.86 | -90.06% | $11.63 | +2543.18% | -2633.24% |
| Sep 11, 2026 | $0.96 | -88.97% | $8.61 | +1856.82% | -1945.79% |
| Sep 10, 2026 | $0.98 | -88.72% | $6.18 | +1304.55% | -1393.27% |
| Sep 09, 2026 | $1.04 | -88.05% | $5.98 | +1259.09% | -1347.14% |
| Sep 08, 2026 | $1.11 | -87.24% | $- | - | |
| Sep 04, 2026 | $1.10 | -87.36% | $0.24 | -45.23% | -42.13% |
| Sep 03, 2026 | $1.16 | -86.67% | $0.25 | -42.73% | -43.94% |
| Sep 02, 2026 | $1.25 | -85.63% | $0.28 | -35.68% | -49.95% |
Page 1 of 5